Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-31 @ 8:02 PM
Study NCT ID:
NCT01427933
Status:
COMPLETED
Last Update Posted:
2017-02-06
First Post:
2011-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-08-31
First Submit QC Date:
None
Study First Post Date:
2011-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-07-29
Results First Submit QC Date:
None
Results First Post Date:
2014-08-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-05-13
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-12-09
Last Update Post Date:
2017-02-06
Last Update Post Date Type:
ESTIMATED